1 | ENTPD1, NT5E
|
| CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
|
| Bono MR, Fernández D, Flores-Santibáñez F, Rosemblatt M, Sauma D.
|
| FEBS Lett 589(22):3454-60. doi: 10.1016/j.febslet.2015.07.027. Review.
2015
|
2 | CD73, NT5E
|
| CD73, a novel cell surface antigen that characterizes retinal photoreceptor precursor cells.
|
| Koso H, Minami C, Tabata Y, Inoue M, Sasaki E, Satoh S, Watanabe S.
|
| Invest Ophthalmol Vis Sci. 50(11):5411-8. 2009
|
3 | NT5E
|
| CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis.
|
| Mikhailov A, Sokolovskaya A, Yegutkin GG, Amdahl H, West A, Yagita H, Lahesmaa R, Thompson LF, Jalkanen S, Blokhin D, Eriksson JE.
|
| J Immunol 181(1):464-75. 2008
|
4 | NT5E
|
| Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells.
|
| Wang L, Zhou X, Zhou T, Ma D, Chen S, Zhi X, Yin L, Shao Z, Ou Z, Zhou P.
|
| J Cancer Res Clin Oncol 134(3):365-72. Epub 2007 Aug 2. 2008
|
5 | NT5E
|
| CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis.
|
| Mills JH, Thompson LF, Mueller C, Waickman AT, Jalkanen S, Niemela J, Airas L, Bynoe MS.
|
| Proc Natl Acad Sci U S A 105(27):9325-30. Epub 2008 Jun 30. 2008
|
6 | NT5E, TNC
|
| Tenascin C interacts with ecto-5'-nucleotidase (eN) and regulates adenosine generation in cancer cells.
|
| Sadej R, Inai K, Rajfur Z, Ostapkowicz A, Kohler J, Skladanowski AC, Mitchell BS, Spychala J.
|
| Biochim Biophys Acta 1782(1):35-40. Epub 2007 Nov 13.PMID: 18062933 2008
|
7 | NT5E
|
| Expression of ecto-5'-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma.
|
| Sadej R, Spychala J, Skladanowski AC.
|
| Melanoma Res 16(3):213-22. 2006
|
8 | POLG2, CDR2, RCVRN, APBB1, MAP6, CLPB, PKIA, ADIPOR1, CYB5R1, GUK1, ADCY2, MEF2C, NT5E
|
| Expression profiling of the developing and mature Nrl-/- mouse retina: identification of retinal disease candidates and transcriptional regulatory targets of Nrl.
|
| Yoshida S, Mears AJ, Friedman JS, Carter T, He S, Oh E, Jing Y, Farjo R, Fleury G, Barlow C, Hero AO, Swaroop A.
|
| Hum Mol Genet 13(14):1487-503. Epub 2004 May 26. 2004
|
9 | NT5E
|
| Primary structure of human placental 5'-nucleotidase and identification of the glycolipid anchor in the mature form.
|
| Misumi Y, et al.
|
| Eur J Biochem 191(3):563-9. 1990
|
10 | NT5E
|
| Regional localization of human ecto-5' nucleotidase to chromosome 6q14-q21.
|
| Boyle JM, Hey Y, Grzeschik KH, Thompson L, Munro E, Fox M.
|
| Hum Genet 83 : 179-180. 1989
|
11 | NT5E
|
| Human ecto-5' nucleotidase maps to chromosome 6q14-q21.
|
| Boyle JM, et al.
|
| (HGM10) Cytogenet Cell Genet 51 : 968. 1989
|
12 | NT5E
|
| Assignment of ecto-5'-nucleotidase to human chromosome 6.
|
| Boyle JM, Hey Y, Guerts van Kessel A, Fox M.
|
| Hum Genet 81 : 88-92. 1988
|
13 | NT5E
|
| Association of a lymphocyte purine enzyme deficiency (5'-nucleotidase) with combined immunodeficiency.
|
| Cohen A, et al.
|
| Clin Immunol Immunopathol 15 : 245-250. 1980
|
14 | NT5E
|
| Lymphocyte ecto-5'-nucleotidase deficiency in agammaglobulinemia.
|
| Edwards NL, et al.
|
| Science 201 : 628-630. 1978
|